CN106139249A - A kind of preparation method of multipolymer artificial cornea - Google Patents

A kind of preparation method of multipolymer artificial cornea Download PDF

Info

Publication number
CN106139249A
CN106139249A CN201610563733.5A CN201610563733A CN106139249A CN 106139249 A CN106139249 A CN 106139249A CN 201610563733 A CN201610563733 A CN 201610563733A CN 106139249 A CN106139249 A CN 106139249A
Authority
CN
China
Prior art keywords
cornea
preparation
multipolymer
artificial cornea
extracellular matrix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201610563733.5A
Other languages
Chinese (zh)
Other versions
CN106139249B (en
Inventor
王红
韩芳芳
王克响
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangzhou Youni Zhikang Biotechnology Co ltd
Qingdao Santie Biotechnology Co ltd
Original Assignee
Qingdao Sandi Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qingdao Sandi Biotechnology Co Ltd filed Critical Qingdao Sandi Biotechnology Co Ltd
Priority to CN201610563733.5A priority Critical patent/CN106139249B/en
Publication of CN106139249A publication Critical patent/CN106139249A/en
Application granted granted Critical
Publication of CN106139249B publication Critical patent/CN106139249B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3633Extracellular matrix [ECM]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/18Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3691Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/02Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
    • C08G63/06Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
    • C08G63/08Lactones or lactides
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/64Polyesters containing both carboxylic ester groups and carbonate groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/16Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)

Abstract

The invention discloses the preparation method of a kind of multipolymer artificial cornea, step includes: 1) synthesis multi-component copolymer material: takes the mixing of various of monomer raw material, adds catalyst, evacuation, inflated with nitrogen, react, prepare multiple copolymer in airtight container;2) cornea three-dimensional rack is prepared: using 3D biometric print machine, use multiple copolymer is raw material, prints the 3 D stereo support of cornea shape;3) utilize ECM that three-dimensional rack carries out functionalized modification: to take de-cell corneal extracellular matrix dry powder and be dissolved in distilled water, by the extracellular matrix granule uniform fold in suspension to cornea three-dimensional rack surface;4) structure of remaining cornea micro-assembly robot method: take patient's cornea and carry out micro-assembly robot process, be injected into and be modified in timbering material, prepares a kind of excellent in mechanical performance, the artificial cornea that biocompatibility is good.

Description

A kind of preparation method of multipolymer artificial cornea
Technical field
The invention belongs to human body implanted medical device technology technical field, particularly relate to a kind of multiple aggregation utilizing synthesis Thing prepares the method for artificial cornea.
Background technology
People's corneal stroma accounts for the 90% of corneal thickness, mainly by the extracellular matrix such as keratocyte and collagen fiber Composition is regularly arranged to be formed, transparent and have certain radius of curvature, beneficially light by and warpage, maintain whole cornea Transparency and the aspect such as bent light rate there is vital effect.The sick blind patient of most corneal stromas all can pass through angle Film transplant operation is cured, but due to contribute the height scarcity of cornea cause Most patients to can not get donor's cornea and cannot Recover lost eyesight, cause many cornea Diseases to be chronically at and wait that donor is contributed and in blind misery.Therefore exploitation one is come Source is convenient, and alternative donor is contributed the artificial cornea of cornea and just become increasingly important and urgent.
Cornea,artificial's timbering material mainly by synthesising biological material and to ECM(extracellular matrix) relevant biomaterial group Become.The advantage of synthesising biological material is to provide the biomechanical property of excellence, and endless supply, transmittance is high and plastic Property strong feature, shortcoming is that hydrophilic is poor, lacks biological activity, and may induce the problems such as a series of inflammatory reaction.Close Become and biomaterial add ECM composition, it is possible to for seed cell create one contribute to cell adhesion, breed or break up natural Microenvironment.
3D printing technique is a rapid shaping technique based on ejection-type, can be easily controlled local material composition, Microstructure and surface characteristic, may apply in the preparation of tissue engineering comea.
Summary of the invention
The present invention relates to the preparation method of a kind of multipolymer artificial cornea, obtain a kind of excellent in mechanical performance, biological The artificial cornea that the compatibility is good.
The technical scheme used for achieving the above object is: the preparation method of a kind of multipolymer artificial cornea, step Including:
1) synthesis multi-component copolymer material: taking the mixing of various of monomer raw material, add catalyst, evacuation, inflated with nitrogen, in airtight appearance Device reacts, prepares multiple copolymer;
2) cornea three-dimensional rack is prepared: use 3D biometric print machine, be the material that raw material is placed in printer by above-mentioned multiple copolymer In Tong, according to model set in advance, print the 3 D stereo support of cornea shape;
3) utilize ECM that three-dimensional rack carries out functionalized modification: to take de-cell corneal extracellular matrix dry powder and be dissolved in distilled water, system Standby one-tenth nano-particle suspension, uses the mode directly coated by the extracellular matrix granule uniform fold in suspension to cornea Three-dimensional rack surface;
4) structure of remaining cornea micro-assembly robot method: take patient's cornea and carry out micro-assembly robot process, be prepared as the trickleest Granule, centrifugal collecting precipitation, precipitation adds biological fibrin glue, aseptically, is injected into and is modified support material In material, prepare artificial cornea.
In order to control the molecular weight of multiple copolymer, in described step 1), reaction temperature is 130-160 DEG C, and the response time is 10-24h。
In order to meet the mechanical strength of artificial cornea, in described step 1), the molecular weight of multiple copolymer is 3000- 50000。
In order to meet the demand of artificial cornea's optical property, mechanical strength and degradation property, monomer choosing in described step 1) Several combinations in 6-caprolactone, lactide, trimethylene carbonate or ethylene glycol, mass ratio during use is, ε-own interior Ester: lactide: trimethylene carbonate: ethylene glycol=5-90:5-90:3-50:5-30.
In order to accelerate multiple aggregation reaction, in described step 1), catalyst is stannous octoate, organic guanidine, metallic zinc, three fourths Base stannic chloride, ferric acetyl acetonade, zinc lactate, nano zine oxide, taurine, ethanol ferrum, normal propyl alcohol ferrum or n-butyl alcohol ferrum;Catalyst The 0.1%-1% that quality is raw materials quality.
Further, described step 2) in a diameter of 200 μm of printhead, extruded velocity is 0.022-0.033mm/s, prints Temperature is 120 DEG C-180 DEG C, and print speed is 6mm/s, and printing thickness is 0.01-0.1mm.
In order to improve the biocompatibility of three-dimensional rack, it is ensured that cell can be survived on support, described step 2) in beat The porosity of the cornea three-dimensional rack that print obtains is 90%, and pore diameter is 200-500 m.
Further, in described step 3), the preparation method of de-cell corneal extracellular matrix dry powder is: by fresh animal Cornea be put in normal saline clean drain after be cut into small pieces, use hydrogen peroxide dipping;Re-use distilled water and tri-distilled water is clear Wash clean, after antibacterial culturing is negative, uses fritter cornea ultra micro waterproof pulverization, centrifugation, collects precipitation, lyophilization It is prepared as de-cell corneal extracellular matrix nanoscale dry powder, preserves at 4 DEG C.
In order to improve centrifugal effect, reducing the particle diameter of de-cell corneal extracellular matrix granule, described being centrifuged is at 4 DEG C of bars Being centrifuged in three times under part, centrifugation time is respectively 10-20min, and centrifugal speed is respectively 1000rmp-8000rmp, and three times from The speed of the heart is incremented by.
Compared with prior art, advantages of the present invention and good effect are: the method comprises the steps of firstly, preparing one and have excellent power Learn the multipolymer material of performance, utilize 3D printing technique to prepare cornea three-dimensional rack with multipolymer for raw material;Then Utilize de-cell corneal extracellular matrix dry powder (ECM) that three-dimensional rack carries out functionalized modification, use 3D printing type or use Directly coating mode by extracellular matrix granule uniform fold to cornea three-dimensional rack surface;Finally by the remaining cornea of patient Carry out " micro-assembly robotization process ", also will be compound in cornea three-dimensional rack by auto corneal " seed cell ", promote artificial angle The optimum microenvironment of film, it is to avoid the In vitro culture link of seed cell, has the application prospect that rapid clinical converts.
Detailed description of the invention
Below in conjunction with detailed description of the invention, technical scheme is described in further detail.The present invention is previously mentioned Ratio, " part ", without special labelling, be all as the criterion with weight.
The invention provides the preparation method of a kind of artificial cornea, the method utilizing chemosynthesis, a kind of mechanical property of preparation The adjustable synthesising biological material of energy, utilizes 3D printing technique to print artificial cornea's support, in order to improve its biocompatibility, uses ECM carries out biological function sex modification so that it is on the premise of having excellent mechanical performances, obtains the biological activity of excellence.Step Including:
1) synthesis multi-component copolymer material: taking the mixing of various of monomer raw material, add catalyst, evacuation, inflated with nitrogen, in airtight appearance In device, reacting under the conditions of anhydrous and oxygen-free, temperature is 130-160 DEG C, and the response time is 10-24h;To produce after having reacted Thing is dissolved in dichloromethane or ethyl acetate, adds methanol or petroleum ether makes multiple copolymer precipitate, filter, will be deposited in 30- It is vacuum dried under the conditions of 50 DEG C, obtains multiple copolymer.
The molecular weight being controlled multiple copolymer by reaction temperature and response time is 3000-50000.Dividing of multiple copolymer Son amount affects the mechanical property of three-dimensional rack, including hot strength, elastic modelling quantity and the elongation at break of support, the present embodiment Middle-molecular-weihydroxyethyl aggregative indicator of mechanical property in the range of 3000-50000 is the most excellent, meets cornea clinically to power Learn all demands of intensity;And slow less than molecular weight of the big polymer degradation rate of molecular weight.
It is several that monomer described in the present embodiment is selected from 6-caprolactone, lactide, trimethylene carbonate or ethylene glycol Combination, mass ratio during use is, 6-caprolactone: lactide: trimethylene carbonate: ethylene glycol=5-90:5-90:3-50:5- 30.When only using two of which or when three kinds, still meet above mass ratio relation, such as, use 6-caprolactone and lactide two During unit's monomer, the two mass ratio is 5-90:5-90;And for example use 6-caprolactone, lactide, trimethylene carbonate termonomer Time, three's mass ratio is 5-90:5-90:3-50.Wherein said lactide can be levorotatory lactide and/or dextrorotation lactide.
Described catalyst is stannous octoate, organic guanidine, metallic zinc, tributyltin chloride, ferric acetyl acetonade, zinc lactate, receives Rice zinc oxide, taurine, ethanol ferrum, normal propyl alcohol ferrum or n-butyl alcohol ferrum.The quality of catalyst is the 0.1%-1% of raw materials quality, excellent Elect 0.5% as.
2) cornea three-dimensional rack is prepared: use the 3D biometric print machine of stepping motorized motions, by above-mentioned multiple copolymer be Raw material is placed in the barrel of printer, and once printing needs raw material 8-12g, according to model set in advance, by multiple copolymer Material is extruded on the print platform being loaded with sterilizing glass film plates, prints the 3 D stereo support of cornea shape.Printhead is straight Footpath is 200 μm, and extruded velocity is 0.022-0.033mm/s, and print temperature is 120 DEG C-180 DEG C, preferably 150 DEG C, prints speed Degree is 6mm/s, and printing thickness is 0.01-0.1mm.
The technological parameter that above-mentioned 3D prints can affect the precision of three-dimensional rack, and influences each other between them, and such as (1) is beaten Print head diameter, directly affects the thickness of printout fiber, also relevant with the size of material.(2) print temperature, has influence on The viscosity of material, feed pressure, forming and hardening speed etc., thus remote-effects formed precision.(3) print speed, squeezes with material Go out speed, material viscosity, material curing molding speeds match, too fast not easy-formation or fracture of wire occurs, material stacking occurs the most slowly. (4) printing thickness, itself be printing precision index, thickness is excessive, it is desirable to extruded velocity is high, is difficult to reality when material viscosity is too high Existing.Thickness arranges relevant to material viscosity, print temperature, print speed, extruded velocity.
Printing the porosity of cornea three-dimensional rack obtained is 90%, and pore diameter is 200-500 m, described porosity and The biocompatibility of support is had a significant impact by pore diameter, and porosity determines nutrient substance and the transmission of oxygen, pore diameter Affecting cell growth requisite space, the two directly determines that cells containing sequences is survived on support.
3) utilize ECM that three-dimensional rack carries out functionalized modification: to take de-cell corneal extracellular matrix dry powder and be dissolved in distilled water In, it is prepared as nano-particle suspension, above-mentioned three-dimensional rack is soaked in suspension, use the mode of directly coating by suspendible Extracellular matrix granule uniform fold in liquid, to cornea three-dimensional rack surface, saves backup at 4 DEG C.
The preparation method of described de-cell corneal extracellular matrix dry powder is: fresh animal cornea is put in normal saline In clean drain after be cut into small pieces, use hydrogen peroxide dipping, the mass concentration of hydrogen peroxide is 3%, and soak time is 10-24h;Again Use distilled water and tri-distilled water to clean up, after antibacterial culturing is negative, fritter cornea is used ultra micro waterproof pulverization, at 4 DEG C Under the conditions of be centrifuged in three times, centrifugation time is respectively 10-20min, and centrifugal speed is respectively 1000rmp-8000rmp, and three times Centrifugal speed is incremented by;Collecting precipitation, lyophilization is prepared as de-cell corneal extracellular matrix nanoscale dry powder, averagely A diameter of 130-180nm, preserves at 4 DEG C.
4) structure of remaining cornea micro-assembly robot method: take patient's cornea, remove degradation degeneration tissue, retain and " align mutually Often " tissue is standby.Remnants cornea tissue is carried out micro-assembly robot process, aseptically transfers to the training in superclean bench Supporting in ware, be cut into small pieces, transfer in the vial disinfected, adding 1-5 L mass concentration is the collagenase of 0.1%-1%, uses In cornea tissue is separated into individual cells, fully shred, be prepared as uniform remaining cornea tissue suspension, by 300 The strainer filtering of m diameter, centrifugal, discard supernatant collection precipitation, precipitation adds 1-5mL biological fibrin glue, for adhesion ECM, prevents it from oozing out;Aseptically, it is injected into and is modified in timbering material.
The present invention use multipolymer synthetic material disclosure satisfy that artificial cornea's optical property, mechanical strength and The demand of degradation property.Utilizing 3D biometric print machine to print cornea three-dimensional rack, precision is high.Utilize de-cell cornea extracellular Substrate corneal three-dimensional rack carries out functionalized modification so that the cornea support after modification has good extracellular matrix micro-loop Border, on the premise of having excellent mechanical performances, it is thus achieved that the most outstanding biocompatibility, and can play cell further The epimatrix regulation and control to cell behavior, the effect promote cell migration, breeding and breaking up, so that the support after Xiu Shiing has Preferably promote the effect of cornea regeneration.Meanwhile, patient remnants' cornea micro-assembly robotization processes and is obtained in that autologous kind is careful Born of the same parents, promote " the optimum microenvironment " of tissue engineering comea, have the application prospect quickly converted to clinic.
Embodiment 1
Artificial cornea is prepared with following steps:
(1) synthesis of binary copolymerization material: take the 6-caprolactone monomer of 35% by mass percentage, the lactide monomer of 65% is former Material puts in consersion unit, and the stannous octoate of addition raw materials quality 0.5% is as catalyst, evacuation, and inflated with nitrogen, airtight In polymerization unit, under the conditions of 150 DEG C, react 20h, the multiple copolymer that molecular weight is 22938 can be obtained.
(2) print cornea three-dimensional rack: with above-mentioned ternary polymerization material as raw material, utilize biometric print machine, build people The 3 D stereo structure of cornea shape, the pore diameter of structure is 350 m, and porosity is 90%, and obtaining can the cornea of load cells Three-dimensional rack.A diameter of 200 μm of printhead, extruded velocity is 0.022mm/s, and print temperature is 120 DEG C, and print speed is 6mm/ S, printing thickness is 0.1mm.
(3) utilize de-cell corneal extracellular matrix that 3D print carriage carries out functionalized modification: to take fresh Oculus sus domestica canthus Film, normal saline is cleaned after draining and is cut into small pieces, soaks the hydrogen peroxide 20 hours of 3%, after distilled water and tri-distilled water clean up, By cornea fritter ultra micro waterproof pulverization, being centrifuged in three times under the conditions of 4 DEG C, centrifugation time is followed successively by 10min, 15min, 20min, from Heart speed is followed successively by 1000rmp, 5000 rmp, 8000rmp;Collecting precipitation, lyophilization is prepared as at 4 DEG C of dry powder preserving, dry The a diameter of 150-180nm of powder.De-cell corneal extracellular matrix dry powder is dissolved in distilled water, is prepared as nano-particle suspendible Liquid, is soaked into printed CF in suspension, and by the mode of coating by the extracellular matrix granule in suspension It is uniformly distributed in CF surface, saves backup at 4 DEG C.
(4) structure of remaining cornea micro-assembly robot method: if taking the remaining cornea after corneal injury patient's cornea excises entirely Dry, remove degradation degeneration tissue, retain " the most normal " tissue standby.Aseptically transfer to surpass by remnants cornea tissue In clean workbench, being cut into small pieces, be then transferred in the vial disinfected in culture dish, adding 2 L mass concentrations is The collagenase of 0.1%, fully shreds, and is prepared as uniform remaining cornea tissue suspension, by the strainer filtering of 300 m diameters, Centrifugal, discard supernatant collection precipitation, precipitation adds 3mL biological fibrin glue, aseptically, is injected into and is repaiied In decorations timbering material.
Artificial cornea prepared by the present embodiment, hot strength is 2.3MPa, and elastic modelling quantity is 4.2MPa, fully meets tissue The engineering cornea demand to mechanical strength.
Embodiment 2
Artificial cornea is prepared with following steps:
(1) synthesis of ternary polymerization material: take the 6-caprolactone monomer of 5%-90%, the lactide of 5%-90% by mass percentage The trimethylene carbonate monomer of monomer and 3%-50% is that raw material puts in consersion unit, and adding quality is input raw materials quality 0.5% tributyltin chloride as catalyst, evacuation, inflated with nitrogen, in airtight polymerization unit, under the conditions of 158 DEG C React 20 hours, the multiple copolymer that molecular weight is 48338 can be obtained.
(2) print cornea three-dimensional rack: with above-mentioned ternary polymerization material as raw material, utilize biometric print machine, build people The 3 D stereo structure of cornea shape, the pore diameter of structure is 250 m, and porosity is 90%, and obtaining can the cornea of load cells Three-dimensional rack.A diameter of 200 μm of printhead, extruded velocity is 0.028mm/s, and print temperature is 150 DEG C, and print speed is 6mm/ S, printing thickness is 0.05mm.
(3) utilize de-cell corneal extracellular matrix that 3D print carriage carries out functionalized modification: to take fresh Oculus sus domestica canthus Film, normal saline is cleaned after draining and is cut into small pieces, soaks 3% hydrogen peroxide 18h, after distilled water and tri-distilled water clean up, by cornea Fritter ultra micro waterproof pulverization, is centrifuged under the conditions of 4 DEG C in three times, and centrifugation time is followed successively by 10min, 10min, 10min, centrifugal speed It is followed successively by 3000rmp, 6000 rmp, 9000rmp;Collecting precipitation, lyophilization is prepared as at 4 DEG C of dry powder preserving, dry powder diameter For 130-150nm.De-cell corneal extracellular matrix dry powder is dissolved in distilled water, is prepared as nano-particle suspension, will beat Printed CF is soaked in suspension, makes the extracellular matrix granule in suspension be uniformly distributed in by the mode of coating CF surface, saves backup at 4 DEG C.
(4) structure of remaining cornea micro-assembly robot method: if taking the remaining cornea after corneal injury patient's cornea excises entirely Dry, remove degradation degeneration tissue, retain " the most normal " tissue standby.Aseptically transfer to surpass by remnants cornea tissue In clean workbench, being cut into small pieces, be then transferred in the vial disinfected in culture dish, adding 3 L mass concentrations is The collagenase of 0.5%, fully shreds, and is prepared as uniform remaining cornea tissue suspension, by the strainer filtering of 300 m diameters, Centrifugal, discard supernatant collection precipitation, precipitation adds 4mL biological fibrin glue, aseptically, is injected into and is repaiied In decorations timbering material.
Artificial cornea prepared by the present embodiment, hot strength is 2.68MPa, and elastic modelling quantity is 3.2MPa, fully meets group Weaver's journey cornea demand to mechanical strength.
Embodiment 3
Artificial cornea is prepared with following steps:
(1) synthesis of ternary polymerization material: take by mass percentage 40% 6-caprolactone monomer, the lactide monomer of 40% and The ethylene glycol monomers of 20% is that raw material puts in consersion unit, and input by addition, the zinc lactate of raw materials quality 0.5% is as catalyst, Evacuation, inflated with nitrogen, in airtight polymerization unit, under the conditions of 160 DEG C, react 24h, can obtain molecular weight is 32838 Multiple copolymer.
(2) print cornea three-dimensional rack: with above-mentioned ternary polymerization material as raw material, utilize 3D biometric print machine, build The 3 D stereo structure of people's cornea shape, the pore diameter of structure is 350 m, and porosity is 90%, and obtaining can the angle of load cells Film three-dimensional rack.A diameter of 200 μm of printhead, extruded velocity is 0.033mm/s, and print temperature is 150 DEG C, and print speed is 6mm/s, printing thickness is 0.01mm.
(3) utilize de-cell corneal extracellular matrix that 3D print carriage carries out functionalized modification: to take fresh Oculus sus domestica canthus Film, normal saline is cleaned after draining and is cut into small pieces, soaks the hydrogen peroxide 20 hours of 3%, after distilled water and tri-distilled water clean up, By cornea fritter ultra micro waterproof pulverization, being centrifuged in three times under the conditions of 4 DEG C, centrifugation time is followed successively by 15min, 15min, 20min, from Heart speed is followed successively by 4000rmp, 5000 rmp, 6000rmp;Collecting precipitation, lyophilization is prepared as at 4 DEG C of dry powder preserving, dry The a diameter of 140-160nm of powder.A certain amount of de-cell corneal extracellular matrix dry powder is dissolved in distilled water, is prepared as nanometer Grain suspension, is soaked into printed CF in suspension, and makes the extracellular base in suspension by the mode of coating Matter granule is uniformly distributed in CF surface, saves backup at 4 DEG C.
(4) structure of remaining cornea micro-assembly robot method: if taking the remaining cornea after corneal injury patient's cornea excises entirely Dry, remove degradation degeneration tissue, retain " the most normal " tissue standby.Remnants cornea is aseptically transferred to ultra-clean work In station, being cut into small pieces in culture dish, be then transferred in the vial disinfected, adding 5 L mass concentrations is the glue of 1% Protoenzyme, fully shreds, and is prepared as uniform remaining cornea tissue suspension, by the strainer filtering of 300 m diameters, centrifugal, abandons Fall supernatant collection precipitation, precipitation adds 5mL biological fibrin glue, aseptically, is injected into and is modified support In material.
Artificial cornea prepared by the present embodiment, hot strength is 2.38MPa, and elastic modelling quantity is 1.6MPa, fully meets group Weaver's journey cornea demand to mechanical strength.
Above example is only several in the several preferred implementation of the present invention, it is noted that the invention is not restricted to Above-described embodiment;For the person of ordinary skill of the art, still can be to the technical scheme described in previous embodiment Modify, or wherein portion of techniques feature is carried out equivalent;And these amendments or replacement, do not make relevant art side The essence of case departs from the spirit and scope of claimed technical solution of the invention.

Claims (9)

1. the preparation method of a multipolymer artificial cornea, it is characterised in that step includes:
1) synthesis multi-component copolymer material: taking the mixing of various of monomer raw material, add catalyst, evacuation, inflated with nitrogen, in airtight appearance Device reacts, prepares multiple copolymer;
2) cornea three-dimensional rack is prepared: use 3D biometric print machine, be the material that raw material is placed in printer by above-mentioned multiple copolymer In Tong, according to model set in advance, print the 3 D stereo support of cornea shape;
3) utilize ECM that three-dimensional rack carries out functionalized modification: to take de-cell corneal extracellular matrix dry powder and be dissolved in distilled water, system Standby one-tenth nano-particle suspension, uses the mode directly coated by the extracellular matrix granule uniform fold in suspension to cornea Three-dimensional rack surface;
4) structure of remaining cornea micro-assembly robot method: take patient's cornea and carry out micro-assembly robot process, be prepared as the trickleest Granule, centrifugal collecting precipitation, precipitation adds biological fibrin glue, aseptically, is injected into and is modified support material In material, prepare artificial cornea.
The preparation method of a kind of multipolymer artificial cornea the most according to claim 1, it is characterised in that described step 1) in, reaction temperature is 130-160 DEG C, and the response time is 10-24h.
The preparation method of a kind of multipolymer artificial cornea the most according to claim 1, it is characterised in that described step 1) in, the molecular weight of multiple copolymer is 3000-50000.
The preparation method of a kind of multipolymer artificial cornea the most according to claim 1, it is characterised in that described step 1) monomer several combinations in 6-caprolactone, lactide, trimethylene carbonate or ethylene glycol, mass ratio during use in For, 6-caprolactone: lactide: trimethylene carbonate: ethylene glycol=5-90:5-90:3-50:5-30.
The preparation method of a kind of multipolymer artificial cornea the most according to claim 1, it is characterised in that described step 1) in catalyst be stannous octoate, organic guanidine, metallic zinc, tributyltin chloride, ferric acetyl acetonade, zinc lactate, nano zine oxide, Taurine, ethanol ferrum, normal propyl alcohol ferrum or n-butyl alcohol ferrum;The quality of catalyst is the 0.1%-1% of raw materials quality.
6. according to the preparation method of a kind of multipolymer artificial cornea described in any one of claim 1-5, it is characterised in that Described step 2) in a diameter of 200 μm of printhead, extruded velocity is 0.022-0.033mm/s, and print temperature is 120 DEG C-180 DEG C, print speed is 6mm/s, and printing thickness is 0.01-0.1mm.
The preparation method of a kind of multipolymer artificial cornea the most according to claim 6, it is characterised in that described step 2) porosity printing the cornea three-dimensional rack obtained in is 90%, and pore diameter is 200-500 m.
The preparation method of a kind of multipolymer artificial cornea the most according to claim 6, it is characterised in that described step 3) in, the preparation method of de-cell corneal extracellular matrix dry powder is: is put in normal saline by fresh animal cornea and cleans drip It is cut into small pieces after Gan, uses hydrogen peroxide dipping;Re-use distilled water and tri-distilled water cleans up, after antibacterial culturing is negative, will Fritter cornea uses ultra micro waterproof pulverization, centrifugation, collects precipitation, and lyophilization is prepared as de-cell corneal extracellular matrix Nanoscale dry powder, preserves at 4 DEG C.
The preparation method of a kind of multipolymer artificial cornea the most according to claim 8, it is characterised in that described centrifugal Being to be centrifuged in three times under the conditions of 4 DEG C, centrifugation time is respectively 10-20min, and centrifugal speed is respectively 1000rmp-8000rmp, And three centrifugal speed is incremented by.
CN201610563733.5A 2016-07-18 2016-07-18 A kind of preparation method of multipolymer artificial cornea Active CN106139249B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610563733.5A CN106139249B (en) 2016-07-18 2016-07-18 A kind of preparation method of multipolymer artificial cornea

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610563733.5A CN106139249B (en) 2016-07-18 2016-07-18 A kind of preparation method of multipolymer artificial cornea

Publications (2)

Publication Number Publication Date
CN106139249A true CN106139249A (en) 2016-11-23
CN106139249B CN106139249B (en) 2019-06-04

Family

ID=58059203

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610563733.5A Active CN106139249B (en) 2016-07-18 2016-07-18 A kind of preparation method of multipolymer artificial cornea

Country Status (1)

Country Link
CN (1) CN106139249B (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1460715A (en) * 2003-05-22 2003-12-10 上海第二医科大学附属第九人民医院 Production method of transplanting material
CN104546222A (en) * 2015-02-02 2015-04-29 深圳华明生物科技有限公司 Artificial cornea and manufacturing method thereof
CN104768586A (en) * 2012-09-04 2015-07-08 人类起源公司 Methods of tissue generation
CN104822342A (en) * 2012-10-08 2015-08-05 矩阵心血管疾病有限公司 Method and system for treating biological tissue
CN105034369A (en) * 2015-07-10 2015-11-11 青岛尤尼科技有限公司 Three-dimensional (3D) cornea stroma support material and method for constructing three-dimensional cornea stroma support

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1460715A (en) * 2003-05-22 2003-12-10 上海第二医科大学附属第九人民医院 Production method of transplanting material
CN104768586A (en) * 2012-09-04 2015-07-08 人类起源公司 Methods of tissue generation
CN104822342A (en) * 2012-10-08 2015-08-05 矩阵心血管疾病有限公司 Method and system for treating biological tissue
CN104546222A (en) * 2015-02-02 2015-04-29 深圳华明生物科技有限公司 Artificial cornea and manufacturing method thereof
CN105034369A (en) * 2015-07-10 2015-11-11 青岛尤尼科技有限公司 Three-dimensional (3D) cornea stroma support material and method for constructing three-dimensional cornea stroma support

Also Published As

Publication number Publication date
CN106139249B (en) 2019-06-04

Similar Documents

Publication Publication Date Title
Jaipan et al. Gelatin-based hydrogels for biomedical applications
Bencherif et al. Advances in the design of macroporous polymer scaffolds for potential applications in dentistry
Xue et al. Biodegradable and biomimetic elastomeric scaffolds for tissue-engineered heart valves
US11884765B2 (en) Biodegradable elastic hydrogels for bioprinting
Salehi et al. Use of polycaprolactone in corneal tissue engineering: A review
CN111729129B (en) Fine manufacturing of light-operated hybrid cross-linked degradable scaffold and application of light-operated hybrid cross-linked degradable scaffold in bone tissue engineering
CN107349475B (en) The artificial organ engineering skin and preparation method thereof that nano fibrous membrane is layering with stem cell
CN107744602A (en) A kind of preparation method of bio-ink material available for 3D printing
Shirwaiker et al. Scaffolding hydrogels for rapid prototyping based tissue engineering
EP3854423B1 (en) Artificial dermis repair material and preparation method therefor
CN109125808A (en) A kind of biodegradable collagen-based cornea substitute and preparation method thereof
CN108310463B (en) 3D printing biological ink and preparation method thereof
JP6240997B2 (en) Method for producing hydrogel film after vitrification, method for producing hydrogel material, hydrogel film after vitrification, dried hydrogel film after vitrification, and cell sheet
Tarassoli et al. Candidate bioinks for 3D bioprinting soft tissue
CN111249528A (en) Tissue engineering bone based on multilayer cell grid and preparation method thereof
CN112063224A (en) Biological ink and preparation method thereof
CN104548196B (en) A kind of tissue engineering bracket material being crosslinked based on vinyl sulfydryl and preparation method thereof
CN113123120B (en) Preparation method and application of PET (polyethylene terephthalate) cell carrier capable of resisting high-temperature sterilization
CN103143058A (en) Preparation of composite hydrogel tissue engineer cartilage repairing scaffold with biological activity
CN112451746B (en) Preparation method of light-curable sodium alginate hydrogel repair scaffold
CN106139249A (en) A kind of preparation method of multipolymer artificial cornea
CN106236324B (en) Improve the corneal graft Cascading Methods of tissue engineering artificial corneal diopter
CN109467719A (en) Biological hybridization gradient hydrogel bracket and preparation method and application thereof
CN113750292B (en) Biological ink for 3D printing of cornea repair material, preparation method of biological ink and preparation method of cornea repair material
CN114366856B (en) Method for compounding gelatin and collagen into 3D printing biological scaffold

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CP01 Change in the name or title of a patent holder
CP01 Change in the name or title of a patent holder

Address after: North Laoshan Road Licang District 266000 Shandong Province, Qingdao City No. 1022 in the arts and Creative Industry Park 1688 building 205 D2

Patentee after: Qingdao Santie Biotechnology Co.,Ltd.

Address before: North Laoshan Road Licang District 266000 Shandong Province, Qingdao City No. 1022 in the arts and Creative Industry Park 1688 building 205 D2

Patentee before: QINGDAO SANDI BIOTECHNOLOGY Co.,Ltd.

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20191108

Address after: 510000 room 120, building A3, No. 3, Qingxu street, Tianhe District, Guangzhou City, Guangdong Province

Patentee after: Guangzhou youni Zhikang Biotechnology Co.,Ltd.

Address before: North Laoshan Road Licang District 266000 Shandong Province, Qingdao City No. 1022 in the arts and Creative Industry Park 1688 building 205 D2

Patentee before: Qingdao Santie Biotechnology Co.,Ltd.